Gene	aberration type	clinical relevance	treatment (or other association)	trial?	Gene-aberr combi	conclusion
KRAS	amplification	benefit	inhibitor			inhibitor benefit
KRAS	activating mutation	benefit	inhibitor			inhibitor benefit
KRAS	extracellular domain (ECD) mutation	benefit	inhibitor			inhibitor benefit
KRAS	kinase domain duplication (KDD)	benefit	inhibitor			inhibitor benefit